North America Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, and Others)

Publication Month: May 2021 | Report Code: TIPRE00022198 | No. of Pages: 131 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The anticoagulant reversal drug market in North America is expected to grow from US$ 414.7 million in 2019 to US$ 1,037.9 million by 2027; it is estimated to grow at a CAGR of 12.8% from 2019 to 2027.

The US, Canada, and Mexico are major economies in North America. Oral anticoagulants are widely used and are highly effective in preventing thromboembolism among AFib patients. However, the use of anticoagulants may lead to bleeding in AFib patients; thus, anticoagulant reversal drugs are used to prevent bleeding. As per the Centers for Disease Control and Prevention (CDC), in 2018, in the US, AFib was mentioned on around 175,326 death certificates and was the primary cause of death in about 25,845 of those deaths. Additionally, it has also anticipated that 12.1 million people in the US will have AFib by 2030.

According to the report "Beyond the Burden: The Impact of Atrial Fibrillation in Asia Pacific," from Biosense Webster (part of Johnson & Johnson Medical Devices Companies), atrial fibrillation is projected to affect around 72 million people by 2050. Thus, such high prevalence of atrial fibrillation is likely to favor the growth of the market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the anticoagulant reversal drugs market. The North America anticoagulant reversal drugs market is expected to grow at a good CAGR during the forecast period.


Get more information on this report :

North America Anticoagulant Reversal Drug Market Segmentation     

By Product

  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Country

  • North America
    • US
    • Canada
    • Mexico

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Pfizer Inc
  • Octapharma AG
  • AMAG PHARMACEUTICALS, INC.
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • Grifols, S.A.

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Anticoagulant Reversal Drug Market – By Product

1.3.2        Anticoagulant Reversal Drug Market – By Distribution Channel

1.3.3        North America Anticoagulant Reversal Drug Market – By Country

2.           North America Anticoagulant Reversal Drug Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Anticoagulant Reversal Drug Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Anticoagulant Reversal Drug Market- North America PEST Analysis

4.3         Expert Opinion

5.           North America Anticoagulant Reversal Drug Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Atrial Fibrillation (AFib)

5.1.2        Increase in Prevalence of Stroke

5.2         Market Restraints

5.2.1        High Cost of Anticoagulant Reversal Drugs

5.3         Market Opportunities

5.3.1        Increasing Research Activities on Anticoagulant Reversal Drugs

5.4         Future Trends

5.4.1        Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Anticoagulant Reversal Drug Market – North America Analysis

6.1         North America Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis

7.           North America Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 – By Product

7.1         Overview

7.2         Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

7.3         Prothrombin Complex Concentrates

7.3.1        Overview

7.3.2        Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.4         Vitamin K

7.4.1        Overview

7.4.2        Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.5         Protamine

7.5.1        Overview

7.5.2        Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.6         Tranexamic Acid

7.6.1        Overview

7.6.2        Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.7         Idarucizumab

7.7.1        Overview

7.7.2        Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.8         Andexxa

7.8.1        Overview

7.8.2        Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.           North America Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027– By Distribution Channel

8.1         Overview

8.2         Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

8.3         Hospital Pharmacies

8.3.1        Overview

8.3.2        Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.4         Retail Pharmacies

8.4.1        Overview

8.4.2        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

9.           Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1         North America: Anticoagulant Reversal Drugs Market

9.1.1        Overview

9.1.2        North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

9.1.3        US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          US: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)

9.1.3.3          US: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)

9.1.4        Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Canada: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)

9.1.4.3          Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)

9.1.5        Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          Mexico: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)

9.1.5.3          Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on North America Anticoagulant Reversal Drug Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.2.2     Organic Developments Done By Companies

11.3      Inorganic Developments

11.3.1     Overview

11.3.2     Inorganic Developments Done By Companies

Source: The Insight Partners Analysis, Website, Press Releases and Others

12.        COMPANY PROFILES

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Pfizer Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      AMAG PHARMACEUTICALS, INC.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Fresenius Kabi AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6       Key Developments

12.6      Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      CSL Limited

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Grifols, S.A.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

 


 

LIST OF TABLES

Table 1.             US Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             US Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 3.             Canada Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.             Canada Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             Mexico Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             Mexico Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             Glossary of Terms, Anticoagulant Reversal Drug Market

 

LIST OF FIGURES

Figure 1.           Anticoagulant Reversal Drug Market Segmentation

Figure 2.           North America Anticoagulant Reversal Drug Market Overview

Figure 3.           Vitamin K Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market

Figure 4.           Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Anticoagulant Reversal Drug Market - North America PEST Analysis

Figure 7.           Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints

Figure 8.           North America Anticoagulant Reversal Drug Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 1.           Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

Figure 2.           Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 3.           Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 4.           Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 5.           Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 6.           Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 7.           Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 8.           Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 9.           Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 10.        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 11.        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 12.        North America: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 13.        North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

Figure 14.        US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 15.        Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 16.        Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 17.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 18.        Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc
  3. Octapharma AG
  4. AMAG PHARMACEUTICALS, INC.
  5. Fresenius Kabi AG
  6. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  7. CSL Limited
  8. Grifols, S.A.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America anticoagulant reversal drug market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America anticoagulant reversal drug market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the anticoagulant reversal drug market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution 
TIPRE00022198
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing